192 related articles for article (PubMed ID: 31375349)
1. Bone Health in Patients With Inflammatory Bowel Diseases.
Chedid VG; Kane SV
J Clin Densitom; 2020; 23(2):182-189. PubMed ID: 31375349
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
[TBL] [Abstract][Full Text] [Related]
3. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
Von Tirpitz C; Pischulti G; Klaus J; Rieber A; Brückel J; Böhm BO; Adler G; Reinshagen M
Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
Vestergaard P
Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
[TBL] [Abstract][Full Text] [Related]
5. Bone density improves with disease remission in patients with inflammatory bowel disease.
Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
[TBL] [Abstract][Full Text] [Related]
6. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis.
Bernstein CN; Seeger LL; Sayre JW; Anton PA; Artinian L; Shanahan F
J Bone Miner Res; 1995 Feb; 10(2):250-6. PubMed ID: 7754804
[TBL] [Abstract][Full Text] [Related]
7. An Increased Serum N-Terminal Telopeptide of Type I Collagen, a Biochemical Marker of Increased Bone Resorption, Is Associated with Infliximab Therapy in Patients with Crohn's Disease.
Sugimoto K; Ikeya K; Iida T; Kawasaki S; Arai O; Umehara K; Watanabe F; Tani S; Oishi S; Osawa S; Yamamoto T; Hanai H
Dig Dis Sci; 2016 Jan; 61(1):99-106. PubMed ID: 26254083
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis in pediatric patients suffering from chronic inflammatory bowel disease with and without steroid treatment.
Walther F; Fusch C; Radke M; Beckert S; Findeisen A
J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):42-51. PubMed ID: 16819376
[TBL] [Abstract][Full Text] [Related]
9. A controlled study of bone mineral density in patients with inflammatory bowel disease.
Silvennoinen JA; Karttunen TJ; Niemelä SE; Manelius JJ; Lehtola JK
Gut; 1995 Jul; 37(1):71-6. PubMed ID: 7672685
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Low Bone Density in Inflammatory Bowel Disease: Use of Glucocorticoids, Low Body Mass Index, and Smoking.
Even Dar R; Mazor Y; Karban A; Ish-Shalom S; Segal E
Dig Dis; 2019; 37(4):284-290. PubMed ID: 30799399
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density in patients with inflammatory bowel disease: a population-based prospective two-year follow-up study.
Jahnsen J; Falch JA; Mowinckel P; Aadland E
Scand J Gastroenterol; 2004 Feb; 39(2):145-53. PubMed ID: 15000276
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory bowel disease and the risk of osteoporosis and fracture.
Targownik LE; Bernstein CN; Leslie WD
Maturitas; 2013 Dec; 76(4):315-9. PubMed ID: 24139749
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease.
Steell L; Gray SR; Russell RK; MacDonald J; Seenan JP; Wong SC; Gaya DR
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34445056
[TBL] [Abstract][Full Text] [Related]
14. Skeletal morbidity in inflammatory bowel disease.
van Hogezand RA; Hamdy NA
Scand J Gastroenterol Suppl; 2006; (243):59-64. PubMed ID: 16782623
[TBL] [Abstract][Full Text] [Related]
15. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.
Ghishan FK; Kiela PR
Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G191-201. PubMed ID: 21088237
[TBL] [Abstract][Full Text] [Related]
16. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
17. [THE DEFEAT OF BONE TISSUE IN CHILDREN WITH INFLAMMATORY BOWEL DISEASES].
Gabrusskaya TV
Eksp Klin Gastroenterol; 2016; (2):70-8. PubMed ID: 27301121
[TBL] [Abstract][Full Text] [Related]
18. Mutifactorial analysis of risk factors for reduced bone mineral density in patients with Crohn's disease.
Bartram SA; Peaston RT; Rawlings DJ; Walshaw D; Francis RM; Thompson NP
World J Gastroenterol; 2006 Sep; 12(35):5680-6. PubMed ID: 17007022
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in Iranian patients with inflammatory bowel disease.
Zali M; Bahari A; Firouzi F; Daryani NE; Aghazadeh R; Emam MM; Rezaie A; Shalmani HM; Naderi N; Maleki B; Sayyah A; Bashashati M; Jazayeri H; Zand S
Int J Colorectal Dis; 2006 Dec; 21(8):758-66. PubMed ID: 16463035
[TBL] [Abstract][Full Text] [Related]
20. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
